FSFlavia Alassia Sangoi

Flavia Alassia Sangoi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Flavia Alassia Sangoi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Postmortem Detection of Blood Vascular Tumour‐Cell Emboli in 31 Dogs: Macroscopic and Histological Findings

    by Helenize Molozzi, Vanessa Cirinéa Tapia Barraza, Valentina Berté Marcus, Isabela de Aro Jorge Tavares, Maria Vitória Girol Sanches, Beatriz Regina Britz Zimmer, Bruna Karine Britz Zimmer, Flavia Alassia Sangoi, Rafael Almeida Fighera, Glaucia Denise Kommers, et al.

    Despite the high prevalence of neoplastic diseases in dogs, tumour‐cell embolism is poorly documented. This study aimed to characterise the presence and pathological features of distant blood vascular tumour‐cell emboli (TCE) in dogs submitted for necropsy. TCE were histologically confirmed in 31/528 dogs (5.9%) that died or were euthanized due to neoplastic disease, most frequently mammary carcinomas (17/31, 54.8%). In 15/31 dogs (48.4%), TCE were associated with secondary macroscopic lesions, such as haemorrhage, whereas in 16/31 dogs (51.6%), there was no clear association with additional pathological changes. TCE were most commonly observed in the lungs (25/31), kidneys (9/31), adrenals (5/31), brain (5/31), and myocardium (5/31). Macroscopic pulmonary changes included petechiae or suffusions (8/31), and TCE‐associated haemorrhages were also observed in the myocardium (4/31), kidneys (2/31), adrenals (2/31), brain (2/31), and gastrointestinal serosae (2/31). Histological lesions associated with TCE included haemorrhage (18/31), thrombosis (11/31), oedema (8/31), infarcts (7/31), and intimal proliferation and perivascular fibrosis (4/31). Taken together, these findings suggest that blood vascular TCE may be more prevalent in dogs than currently recognised and reinforce the importance of careful pathological evaluation for their detection. The clinical, macroscopic, and microscopic features described herein provide a practical framework for recognising TCE in veterinary pathology and underscore the need for further studies addressing their pathogenesis, clinical significance, and impact on disease progression in dogs.

  • Open Access

    Detection of occult metastases of mammary carcinomas in lymph nodes of dogs by immunohistochemistry combined with histochemistry techniques

    by Vanessa C.T. Barraza, Pedro Henrique S. Buttelli, Indianara de Vargas, Mariana A. Goldani, Alice M. de Medeiros, Flávia A. Sangoi, Mariana M. Flores, Glaucia D. Kommers

    Lymph node status is considered an important clinical prognostic factor in canine mammary carcinomas and women’s breast neoplasms. However, occult isolated tumor cells (ITCs) can be missed during hematoxylin and eosin (HE) analyses. Immunohistochemistry (IHC) for cytokeratin can be used to detect carcinomatous occult ITCs in mammary drainage lymph nodes. However, brown pigments, such as hemosiderin and ceroid in lymph nodes, may hinder the search for occult metastases by IHC utilizing DAB (3,3′-diaminobenzidine) as the chromogen. The aim of this study was to identify ITCs in canine lymph nodes of cases in which it was not detectable by routine HE evaluation through IHC for cytokeratin (AE1/AE3) combined with histochemistry techniques, such as Perls’ Prussian blue and periodic acid-Schiff (PAS), to improve the detection of occult metastases when hemosiderin and ceroid were present in these lymph nodes. For this, 25 tubulopapillary mammary carcinomas with their respective submitted 29 regional lymph nodes, previously given as free of tumor cells by HE analyses, were selected. Mammary tumors were graduated, and vascular invasion was investigated in these tumors. The submitted lymph nodes were reevaluated in HE, looking for occult metastases. IHC for cytokeratin (AE1/AE3) was used to detect occult metastases in mammary lymph nodes. Subsequently, a combined technique of IHC with Perl’s Prussian blue (for hemosiderin) or PAS (for ceroid) was performed to optimize the detection of ITCs by IHC, distinguishing them from pigments. Occult metastases were classified by their microanatomical location in subcapsular, cortical and medullary. Hemosiderin and ceroid were searched in lymph nodes and quantified as low, moderate, or high. The amount of pigments with a percentage of ITCs was also compared. Isolated tumor cells were found in 24.1% (7/29) of mammary lymph nodes. These ITCs were located mainly in subcapsular sinuses (4/7; 57.1%), followed by cortical (2/7; 28.5%) and medullary sinuses (1/7; 14.3%). There were concomitant lymph nodes with ITCs in 33.4% (2/6) of cases with vascular invasion. Hemosiderin and ceroid were present in about 90% of the 29 lymph nodes analyzed. In 42.8% (3/7) of lymph nodes with ITCs, hemosiderin and/or ceroid were in the same location as ITCs. It was found that lymph nodes in which ITCs were detected also present high amounts of hemosiderin (3/7; 42.9%) and low amounts of ceroid (5/7; 71.4%). In this study, IHC for cytokeratin (AE1/AE3) was an efficient method to detect occult tumor cells. IHC combined with Perls’ Prussian blue or with PAS proved to be a helpful way to investigate the presence of occult metastases in the lymph nodes of mammary canine tumors. It allowed distinguishing hemosiderin and ceroid, respectively, from ITCs in the same slide of IHC (immunostained by DAB), favoring a more accurate analysis by pathologists, which can be useful for the oncological staging of these patients.